MACROD1

MACROD1 (also known as LRP16) is a macrodomain-containing mono-ADP-ribose hydrolase that operates in both mitochondria and the nucleus to regulate ADP-ribosylation signaling, DNA damage repair, steroid receptor transcription, and NF-κB activation. Its macrodomain catalyzes hydrolytic removal of ADP-ribose from modified proteins and DNA ends, with crystal structures revealing that Phe272 and a conserved hydrogen-bond network orient the catalytic water for substrate cleavage, and this enzymatic activity is required for recruitment to and repair of DNA damage sites (PMID:32683309, PMID:29410655). In the nucleus, MACROD1 functions as a transcriptional coactivator by directly binding ERα, AR, and the NF-κB p65 subunit, and as a scaffold assembling PARP1–IKKγ and PKR–IKKβ signaling complexes that amplify DNA-damage-induced NF-κB activation and confer chemoresistance (PMID:17914104, PMID:19022849, PMID:21483817, PMID:25735744, PMID:28820388). In mitochondria, where the endogenous protein predominantly localizes, MACROD1 maintains organelle morphology and NAD⁺ homeostasis by restraining PARP1, thereby activating SIRT3-mediated antioxidant responses and protecting against diabetic cardiomyopathy (PMID:32427867, PMID:38459256).

1. 2003 Medium

   Initial characterization established that MACROD1 (LRP16) is an estrogen- and androgen-responsive gene whose overexpression drives cell cycle progression, raising the question of how it contributes to hormone-dependent proliferation.

   Evidence LRP16 promoter assays and flow cytometry in MCF-7 cells showing S-phase entry and cyclin E upregulation

   PMID:12790785

   Open questions at the time

   • No direct interaction with hormone receptors demonstrated
   • Mechanism linking LRP16 to cyclin E induction unknown
2. 2007 High

   The molecular basis of LRP16's role in estrogen signaling was resolved: it physically binds the ERα AF-1 domain and coactivates ERα-dependent transcription, establishing it as a bona fide nuclear receptor coactivator.

   Evidence GST pulldown, co-immunoprecipitation, mammalian two-hybrid, and siRNA knockdown with reporter readout

   PMID:17893710 PMID:17914104 PMID:18206366

   Open questions at the time

   • Whether coactivation requires enzymatic activity was unknown
   • Structural basis of ERα–LRP16 interaction not determined
3. 2008 High

   The coactivator function was generalized beyond ERα: LRP16's macrodomain directly binds androgen receptor and at least four additional nuclear receptors, and RNAi demonstrated functional dependence of AR-driven proliferation on LRP16.

   Evidence Co-IP and GST pulldown mapping the macro domain as the AR-interacting region, luciferase reporter and proliferation assays in LNCaP cells

   PMID:19022849

   Open questions at the time

   • Whether macrodomain enzymatic activity is required for coactivation remained untested
   • In vivo relevance not established
4. 2009 High

   A regulatory mechanism controlling MACROD1 nuclear availability was identified: keratin 18 sequesters it in the cytoplasm, attenuating ERα-mediated transcription and estrogen-driven cell cycle progression.

   Evidence Yeast two-hybrid, GST pulldown, co-IP, nuclear/cytoplasmic fractionation, and BrdU incorporation in MCF-7 cells

   PMID:20035625

   Open questions at the time

   • Whether K18 interaction is regulated by post-translational modification unknown
   • Physiological contexts where K18 sequestration is rate-limiting not defined
5. 2011 High

   MACROD1 was placed in the NF-κB pathway: it associates with p65, is required for formation of the NF-κB/p300/CBP transactivation complex after TNF-α stimulation, and its loss sensitizes cells to TNF-α-induced apoptosis — distinguishing a role in transactivation from nuclear translocation.

   Evidence GST pulldown, co-IP, luciferase reporter, ChIP, and Annexin V apoptosis assay

   PMID:21483817

   Open questions at the time

   • Whether NF-κB coactivation and steroid receptor coactivation are mutually exclusive or concurrent was unclear
   • No structural detail of p65–LRP16 interface
6. 2015 High

   The scaffold function of MACROD1 in DNA damage-induced NF-κB signaling was defined: it constitutively assembles a PARP1–IKKγ preassembly complex that recruits PIASy for IKKγ SUMOylation after DSBs, in a Ku70/Ku80-dependent manner.

   Evidence Co-IP, GST pulldown, proximity ligation assay, siRNA epistasis, and NF-κB reporter in response to etoposide-induced DSBs

   PMID:25735744

   Open questions at the time

   • Whether MACROD1's hydrolase activity contributes to complex assembly not tested
   • Stoichiometry and dynamics of the preassembly complex unknown
7. 2017 High

   A second scaffold axis was discovered: MACROD1 activates PKR and nucleates a PKR–IKKβ ternary complex that sustains PAR-dependent NF-κB signaling after DNA damage, conferring chemoresistance that can be reversed by the small molecule MRS2578.

   Evidence Co-IP, kinase assays, RNAi, MRS2578 pharmacological disruption, and xenograft tumor model

   PMID:28820388

   Open questions at the time

   • Binding mode of MRS2578 to MACROD1 not structurally resolved
   • Whether PKR scaffold function operates outside DNA damage contexts unknown
8. 2018 High

   The intrinsic enzymatic activity of MACROD1 was biochemically characterized: it is a mono-ADP-ribose hydrolase that removes ADP-ribose from phosphorylated DNA ends, and the endogenous protein localizes predominantly to mitochondria.

   Evidence Subcellular fractionation and immunofluorescence of endogenous protein, in vitro hydrolase assay with phosphorylated dsDNA substrates

   PMID:29410655

   Open questions at the time

   • In vivo mitochondrial substrates not identified
   • Relationship between mitochondrial localization and nuclear coactivator functions unresolved
9. 2020 High

   The structural mechanism of catalysis was determined at atomic resolution: the β5-α10 switch loop mediates substrate recognition, Phe272 orients the distal ribose, and the hydrolase activity is essential for recruitment to and repair of DNA damage sites.

   Evidence X-ray crystallography of MacroD1–ADPR complex, site-directed mutagenesis, in vitro hydrolase assay, live-cell imaging of DNA damage recruitment

   PMID:32683309

   Open questions at the time

   • Whether catalytic-dead mutant retains scaffold/coactivator functions not tested
   • No structure of full-length MACROD1 or in complex with protein substrates
10. 2020 High

    Mitochondrial function was validated with knockout cells: loss of MACROD1 disrupts mitochondrial morphology, and BioID proximity labeling revealed an interactome enriched for mitochondrial RNA metabolism factors.

    Evidence Monoclonal antibody localization, MACROD1 knockout cells, BioID interactome profiling

    PMID:32427867

    Open questions at the time

    • Specific mitochondrial RNA substrates not identified
    • Whether morphology defect is due to loss of hydrolase activity or protein interactions not dissected
11. 2021 Medium

    In vivo loss of Macrod1 produces a female-specific motor coordination defect in mice, linking its mitochondrial function to neuromuscular physiology.

    Evidence Macrod1 knockout mouse model with standardized behavioral testing

    PMID:33578760

    Open questions at the time

    • Molecular mechanism underlying female specificity not determined
    • Tissue-specific basis (skeletal muscle vs. brain) not resolved
12. 2024 Medium

    A cardioprotective axis was delineated: MACROD1 suppresses PARP1, preserving NAD⁺ pools and activating SIRT3-dependent antioxidant signaling, and cardiac-specific overexpression rescues diabetic cardiomyopathy in mice.

    Evidence Macrod1 KO and cardiac-specific overexpression in STZ/HFD diabetic cardiomyopathy mouse model, NAD⁺ measurement, SIRT3 activity assay

    PMID:38459256

    Open questions at the time

    • Whether MACROD1 directly modifies PARP1 ADP-ribosylation or acts indirectly to suppress PARP1 expression not resolved
    • Single-lab finding awaiting independent replication

• The central unresolved question is how MACROD1's enzymatic hydrolase activity, its scaffold/coactivator functions, and its dual mitochondrial–nuclear localization are coordinated in vivo, and what controls the balance between these compartments.
• No in vivo catalytic-dead knock-in to separate enzymatic from scaffold roles
• Mitochondrial targeting signal and regulated nuclear import mechanism not fully defined
• Identity of endogenous mitochondrial ADP-ribosylated substrates unknown